Author

Bogdan Żurawski

Observed name: Bogdan Zurawski

Institution: Centrum Onkologii

Observed institution: Centrum Onkologii

ORCID: 0009-0007-6112-4663

Observed ORCID: 0009-0007-6112-4663

OpenAlex ID: A5114537893

Phase II study of magrolimab combined with docetaxel in previously treated metastatic advanced solid tumors

2026 · Antoine Italiano, Teresa García Manrique, et al. · Frontiers in Oncology · 3

34 Belzutifan Plus Lenvatinib Versus Cabozantinib in Post–PD-(L)1 Renal Cell Carcinoma: Health-Related Quality-of-Life Outcomes in the Phase 3 LITESPARK-011 Study

2026 · Manuela Schmidinger, Daniel Y C Heng, et al. · The Oncologist

Data from Early Detriment Analysis of First-Line Nivolumab plus Ipilimumab–Based Therapy in Patients with Metastatic Non–Small Cell Lung Cancer

2026 · Hossein Borghaei, David Balli, et al.

Supplementary Data 1 from Early Detriment Analysis of First-Line Nivolumab plus Ipilimumab–Based Therapy in Patients with Metastatic Non–Small Cell Lung Cancer

2026 · Hossein Borghaei, David Balli, et al.

Belzutifan plus lenvatinib versus cabozantinib in post–PD-(L)1 renal cell carcinoma (RCC): Health-related quality-of-life (HRQoL) outcomes in the phase 3 LITESPARK-011 study.

2026 · Daniel Yick Chin Heng, Robert J. Motzer, et al. · Journal of Clinical Oncology

Trastuzumab deruxtecan (T-DXd) + durvalumab (D) in patients (pts) with previously untreated HER2+ unresectable/metastatic breast cancer (mBC): Final analysis from DESTINY-Breast07.

2026 · Sherene Loi, Erika P. Hamilton, et al. · Journal of Clinical Oncology

Early Detriment Analysis of First-Line Nivolumab plus Ipilimumab–Based Therapy in Patients with Metastatic Non–Small Cell Lung Cancer

2026 · Hossein Borghaei, David Balli, et al. · Clinical Cancer Research

Corrigendum to ‘MA04.04 Perioperative Pembrolizumab in Non-Small Cell Cancer (NSCLC): 4-Year Outcomes by Nodal Status in the KEYNOTE-671 Study’ [Journal of Thoracic Oncology Volume 20 Issue 10 Supplement 1 (2025) S67]

2026 · Heather A. Wakelee, Ingel Demedts, et al. · Journal of Thoracic Oncology

All Roads Lead to Raphaelion.

2024 · Bogdan Żurawski · Institut français d'archéologie orientale eBooks

Nivolumab + Ipilimumab + 2 Cycles of Platinum-doublet Chemotherapy (chemo) Versus 4 Cycles Chemo as First-line Treatment for Stage Iv/ Recurrent Non-small Cell Lung Cancer (nsclc): Checkmate 9la

2020 · Martin Reck, Tudor-Eliade Ciuleanu, et al. · Brazilian Journal of Oncology

Works count: 10

Citation count: 3

H-index: 1

I10-index: